Development
Vicarious Surgical Inc.
RBOT
$7.58
-$0.07-0.92%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -17.27% | 36.52% | -955.33% | -163.31% | -151.32% |
| Total Depreciation and Amortization | 30.60% | 32.25% | 137.10% | 138.38% | 219.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 433.33% |
| Total Other Non-Cash Items | 130.92% | -120.57% | 87.53% | 116.07% | 86.54% |
| Change in Net Operating Assets | 88.21% | -116.61% | -1.81% | -293.98% | -151.63% |
| Cash from Operations | 38.24% | -24.91% | -6.22% | -25.75% | -88.75% |
| Capital Expenditure | -4.64% | 84.91% | 86.63% | 84.87% | -14.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 608.57% | 17.65% | -308.48% | -2,067.56% | -14.42% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | 97.53% | 92.59% | -462.96% |
| Issuance of Common Stock | -99.66% | 17,929.12% | -24.89% | -74.70% | 3,013.04% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | 53.56% |
| Cash from Financing | -99.61% | 44,133.00% | 174.58% | 56.90% | 1,913.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 40.59% | 281.20% | -35.55% | -273.91% | 4.66% |